Paclitaxel Shows Promise: A Viable Alternative to Cisplatin in Ovarian Cancer HIPEC
2025-07-07

Medscape
For years, cisplatin has been a cornerstone of treatment for advanced ovarian cancer, particularly within the context of Hyperthermic Intraperitoneal Chemotherapy (HIPEC). However, the potential for severe side effects and the desire for alternative ...Leer más